Epidemiological research on safety and efficacy of Yokukansan in the long-term treatment of behavioral and psychological symptoms of dementia.
Phase of Trial: Phase IV
Latest Information Update: 17 May 2012
At a glance
- Drugs TJ 54 (Primary)
- Indications Dementia
- Focus Adverse reactions; Pharmacodynamics
- 17 May 2012 New trial record